CVE-2023-35069
HIGHCVSS 7.5/10EPSS 0.58%
Last modified
CVE-2023-35069 is a high-severity vulnerability rated 7.5/10 on the CVSS scale. Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Bullwark allows Path Traversal. This issue affects Bullwark: before BLW-2016E-960H.. EPSS estimates a 0.58% chance of exploitation in the next 30 days.
Description
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Bullwark allows Path Traversal. This issue affects Bullwark: before BLW-2016E-960H.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Biges | Bullwark Momentum Series | < blw-2016e-960h |
References
- https://www.usom.gov.tr/bildirim/tr-23-0401Third Party Advisory
- https://www.usom.gov.tr/bildirim/tr-23-0401Third Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-35069?
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Bullwark allows Path Traversal.
This issue affects Bullwark: before BLW-2016E-960H.
How severe is CVE-2023-35069?
CVE-2023-35069 has a CVSS score of 7.5/10 (HIGH severity). The EPSS model estimates a 0.58% probability of exploitation in the next 30 days.
How do I fix CVE-2023-35069?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-35069?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
